Reporter Ross Law and editors Abigail Beaney and Robert Barrie reflect on a busy 2025, along with discusing forecasts for ...
Using the 2 Stage Free Cash Flow to Equity, OKYO Pharma fair value estimate is US$4.57. OKYO Pharma's US$2.40 share price signals that it might be 47% undervalued. O ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback